LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)

Market Cap	6.76B
Revenue (ttm)	501.91M
Net Income (ttm)	261.32M
Shares Out	346.75M
EPS (ttm)	0.75
PE Ratio	25.88
Forward PE	16.81
Dividend	0.67 (3.45%)
Ex-Dividend Date	May 26, 2025

Volume	467,000
Average Volume	3,017,151
Open	20.30
Previous Close	20.10
Day's Range	19.50 - 20.50
52-Week Range	13.00 - 27.70
Beta	-0.21
RSI	45.02
Earnings Date	May 22, 2025

About HKG:2291

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the research, development, manufacture, and commercialization of interventional medical devices worldwide. The company offers congenital heart diseases interventional treatment solutions, including atrial septal defect, ventricular septal defect, and patent ductus arteriosus occluder products; delivery systems; and snare products. It also provides cardioembolic stroke prevention solutions, such as left atrial appendage and patent foramen ovale occl...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Employees: 314
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2291

Financial Performance

In 2024, HKG:2291's revenue was 471.64 million, an increase of 44.40% compared to the previous year's 326.62 million. Earnings were 245.56 million, an increase of 62.22%.

Financial numbers in CNY